RAPT Therapeutics Inc
RAPT7.840USD
+6.810+661.17%
종가 06/17, 16:00（ET）시세는 15분 지연됩니다
1.03B시가총액
손실P/E TTM
자세한 내용은 RAPT Therapeutics Inc 회사
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapies for patients living with inflammatory and immunological diseases. Its lead drug candidate, RPT904, is a half-life extended monoclonal antibody (mAb) designed to bind free human immunoglobin E (IgE), which is being developing for the treatment of food allergy, chronic spontaneous urticaria (CSU) and potentially other inflammatory diseases. The Company’s oncology drug candidate, tivumecirnon, is an oral small-molecule C-C motif chemokine receptor 4 (CCR4) antagonist designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors.
회사 정보
종목 코드 RAPT
회사 이름RAPT Therapeutics Inc
상장일Oct 31, 2019
설립일2015
CEODr. Brian Wong, M.D., Ph.D.
직원 수68
유형Ordinary Share
회계 연도 종료Oct 31
주소561 Eccles Ave
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호94080
전화16504899000
웹사이트https://rapt.com/
종목 코드 RAPT
상장일Oct 31, 2019
설립일2015
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Michael F. Giordano, M.D.
Dr. Michael F. Giordano, M.D.
Independent Director
Independent Director
--
--
Dr. William (Bill) Ho, M.D., Ph.D.
Dr. William (Bill) Ho, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lori Lyons-Williams
Ms. Lori Lyons-Williams
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Brian Wong, M.D., Ph.D.
Dr. Brian Wong, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Dirk Brockstedt, Ph.D.
Dr. Dirk Brockstedt, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Rodney K. B. Young
Mr. Rodney K. B. Young
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Linda Kozick
Ms. Linda Kozick
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Michael F. Giordano, M.D.
Dr. Michael F. Giordano, M.D.
Independent Director
Independent Director
--
--
Dr. William (Bill) Ho, M.D., Ph.D.
Dr. William (Bill) Ho, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lori Lyons-Williams
Ms. Lori Lyons-Williams
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Brian Wong, M.D., Ph.D.
Dr. Brian Wong, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Dirk Brockstedt, Ph.D.
Dr. Dirk Brockstedt, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Medicxi Ventures (UK) LLP
16.90%
OrbiMed Advisors, LLC
9.93%
TCG Crossover Management, LLC
9.90%
Foresite Capital Management, LLC
9.45%
RTW Investments L.P.
8.89%
Other
44.94%
주주
주주
비율
Medicxi Ventures (UK) LLP
16.90%
OrbiMed Advisors, LLC
9.93%
TCG Crossover Management, LLC
9.90%
Foresite Capital Management, LLC
9.45%
RTW Investments L.P.
8.89%
Other
44.94%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
2.96%
Private Equity
2.84%
Hedge Fund
2.64%
Venture Capital
2.25%
Investment Advisor
1.68%
Research Firm
0.08%
Individual Investor
0.06%
Bank and Trust
0.01%
Family Office
0.01%
Other
87.49%
기관 주식 보유
마지막 업데이트: Tue, Mar 4
마지막 업데이트: Tue, Mar 4
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
301
145.36M
110.11%
+83.62M
2024Q4
309
140.52M
106.54%
+100.36M
2024Q3
304
31.22M
87.82%
-13.95M
2024Q2
305
33.18M
93.85%
-9.52M
2024Q1
295
33.76M
95.60%
-5.47M
2023Q4
282
36.46M
106.02%
-3.53M
2023Q3
281
36.40M
105.98%
-3.26M
2023Q2
295
35.63M
103.77%
-4.21M
2023Q1
301
34.71M
101.29%
-3.14M
2022Q4
290
33.55M
97.48%
-1.41M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Medicxi Ventures (UK) LLP
22.35M
16.93%
+22.35M
--
Dec 31, 2024
OrbiMed Advisors, LLC
13.14M
9.95%
+13.14M
--
Dec 31, 2024
TCG Crossover Management, LLC
13.14M
9.95%
+13.14M
--
Dec 31, 2024
Foresite Capital Management, LLC
12.50M
9.47%
+12.50M
--
Dec 31, 2024
RTW Investments L.P.
11.76M
8.91%
+11.76M
--
Dec 31, 2024
BVF Partners L.P.
9.24M
7%
+9.24M
--
Dec 31, 2024
The Vanguard Group, Inc.
2.93M
2.22%
-8.95K
-0.30%
Jan 31, 2025
Redmile Group, LLC
6.48M
4.91%
+5.97M
+1.18K%
Dec 31, 2024
Deep Track Capital LP
6.01M
4.55%
+6.01M
--
Dec 31, 2024
Adar1 Capital Management LLC
1.17M
0.89%
+1.17M
+15.56K%
Dec 31, 2024
더 보기
관련 ETF
마지막 업데이트: Fri, Jun 6
마지막 업데이트: Fri, Jun 6
이름
비율
Federated Hermes MDT Small Cap Core ETF
0.05%
iShares Micro-Cap ETF
0.01%
ProShares UltraPro Russell2000
0%
Nuveen ESG Small-Cap ETF
0%
Avantis US Small Cap Equity ETF
0%
Humankind US Stock ETF
0%
Invesco Dorsey Wright Healthcare Momentum ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Proshares Ultra Russell 2000
0%
더 보기
Federated Hermes MDT Small Cap Core ETF
비율0.05%
iShares Micro-Cap ETF
비율0.01%
ProShares UltraPro Russell2000
비율0%
Nuveen ESG Small-Cap ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%
Humankind US Stock ETF
비율0%
Invesco Dorsey Wright Healthcare Momentum ETF
비율0%
Invesco Nasdaq Biotechnology ETF
비율0%
ProShares Ultra Nasdaq Biotechnology
비율0%
Proshares Ultra Russell 2000
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
